Description
Purna Pharmaceuticals is a family-owned Belgian FDA-inspected company established in 1986, providing services for the development and manufacturing of non-sterile solid, semi-solid and liquid pharmaceutical products that meet GxP standards as well as specific customer-related requirements. Purna has 3 core business units:
- Development (R&D)
Analytical, formulation and process development of finished drug products starting from new chemical entities or existing molecules using DoE approach. Purna is able to handle OEB 1-5, as well as flammables (ATEX).
- Manufacturing (GMP)
Manufacturing of developed pharmaceutical drug products (upscaling) or transfer of existing drug products (technical transfers) incl. analytical method validation and QC release. Batch sizes for liquids: 100 – 10.000L and for semi-solids: 20 – 2.000 L.
- Out-licensing
Purna works together with universities and research centers to bring patented technologies to the market. Purna has projects active in female healthcare, wound care,…
The company specialises in finished dosage forms and offers API development services. Purna serves a global client base and now also supplies drug products to the Chinese market.
Contact Information
AI and Digital Manufacturing Benchmarking Survey
Take this quick 5 minute assessment to benchmark your organisation’s digital and AI maturity — and see how you compare with industry peers.